The effectiveness of afatinib, a second-generation EGFR-TKI, for NSCLC patients in clinical practice

Ohba, T; Toyozawa, R; Nosaki, K; Umeyama, Y; Takamori, S; Haratake, N; Miura, N; Yamaguchi, M; Seto, T; Takenoyama, M; Ichinose, Y

CANCER SCIENCE, 2018; 109 (): 1427

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索